Sfoglia per Autore
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction
1994 Sestini; R.; Orlando; C.; Zentilin; L.; Gelmini; S.; Pinzani; P.; Bianchi; S.; Selli; C.; Giacca; M.; Pazzagli; M.
Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 oncogene amplification in DNA from human tumours.
1994 ORLANDO C; R. SESTINI; ZENTILIN L; GELMINI S; PINZANI P; GIACCA M; PAZZAGLI M
ATP chemosensitivity testing: methodology and comparison with other methods
1994 Pinzani P, Gerli A, Carotti S, Mini E, Orlando C, Gelmini S, Sestini R, Pazzagli M
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE.
1995 SESTINI R; C. ORLANDO; ZENTILIN L; LAMI D; GELMINI S; PINZANI P; GIACCA M; PAZZAGLI M
QUANTITATIVE POLYMERASE CHAIN REACTION-BASED HOMOGENEOUS ASSAY WITH FLUOROGENIC PROBES TO MEASURE C-ERBb-2 ONCOGENE AMPLIFICATION.
1997 GELMINI S; C. ORLANDO; SESTINI R; VONA G; PINZANI P; RUOCCO L; PAZZAGLI M
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors
1998 GELMINI S; CALDINI A; BECHERINI L; CAPACCIOLI S; PAZZAGLI M; C. ORLANDO
Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
2000 SELLI C; GELMINI S; SCOTT CA; GIANNARINI G; C. ORLANDO
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas
2000 M. MANNELLI; GELMINI S.; ARNALDI G.; BECHERINI L.; BEMPORAD D.; CRESCIOLI C.; PAZZAGLI M.; MANTERO F.; SERIO M.; ORLANDO C.
luciferase gene as reporter: comparison with CAT gene and use in transfection and microinjection of mammalian cells
2000 GELMINI S; PINZANI P; M. PAZZAGLI
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
2000 S. Gelmini; A. Crisci; B. Salvadori; M. Pazzagli; C. Selli; C. Orlando
Telomerase in urological malignancy
2001 C. ORLANDO; GELMINI S; SELLI C; PAZZAGLI M.
Telomerase in endocrine and endocrine-dependent tumors.
2001 C. ORLANDO; GELMINI S.
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
2001 Peri A; Luciani P; Conforti B; Baglioni S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
[Somatostatin receptors in non-endocrine tumours].
2001 Casini Raggi C;Pinzani P;Gelmini S;Tricarico C;Orlando C;Calabrò A;Renzi D;Cianchi F;Valanzano R;Distante V;Cortesini C;Tonelli F;Cataliotti L;Cameron Smith M;Messerini L;Bianchi S;Pazzagli M;Serio M;Maggi M
Somatostatin receptors in non-endocrine tumours [Recettori per la somatostatina in tumori non endocrini.]
2001 Casini Raggi; C.; Pinzani; P.; Gelmini; S.; Tricarico; C.; Orlando; C.; Calabrò; A.; Renzi; D.; Cianchi; F.; Valanzano; R.; Distante; V.; Cortesini; C.; Tonelli; F.; Cataliotti; L.; Cameron Smith; M.; Messerini; L.; Bianchi; S.; Pazzagli; M.; Serio; M.; Maggi; M.
Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
2001 S. Gelmini; C. Tricarico; G. Vona; L. Livi; A. D. Melina; S. Serni; E. Cellai; S. Magrini; D. Villari; M. Carini; M. Serio; G. Forti; M. Pazzagli; C. Orlando
The significance of quantitative evaluation of telomerase activity and hTERT mRNA expression in colorectal cancers
2002 Poggesi M; Gelmini S; Casini Raggi C; Cianchi F; Valanzano R; Pazzagli M; Orlando C
Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
2003 Stefania Gelmini; Carmela Tricarico; Luisa Petrone; Gianni Forti; Andrea Amorosi; Giovanni L Dedola; Mario Serio; Mario Pazzagli; Claudio Orlando
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas.
2004 M. LOCATELLI; S. GELMINI; A. PERI; C. ORLANDO; M. FILOPANTI; E. BALLARÈ; A. LANIA; S. BONDIONI; U. VERGA; L. ZAVANONE; M. LOSA; P. BECK; A. SPADA
Resistin as a liver-derived cytokine that targets human hepatic stellate cells
2004 C. Bertolani; S. Aleffi; I. Petrai; B. Mazzinghi; S. Gelmini; P. Failli; C. Orlando; P. Romagnani; M. Parola; F. Marra; F
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction | 1994 | Sestini; R.; Orlando; C.; Zentilin; L.; Gelmini; S.; Pinzani; P.; Bianchi; S.; Selli; C.; Giacca; M.; Pazzagli; M. | |
Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 oncogene amplification in DNA from human tumours. | 1994 | ORLANDO C; R. SESTINI; ZENTILIN L; GELMINI S; PINZANI P; GIACCA M; PAZZAGLI M | |
ATP chemosensitivity testing: methodology and comparison with other methods | 1994 | Pinzani P, Gerli A, Carotti S, Mini E, Orlando C, Gelmini S, Sestini R, Pazzagli M | |
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. | 1995 | SESTINI R; C. ORLANDO; ZENTILIN L; LAMI D; GELMINI S; PINZANI P; GIACCA M; PAZZAGLI M | |
QUANTITATIVE POLYMERASE CHAIN REACTION-BASED HOMOGENEOUS ASSAY WITH FLUOROGENIC PROBES TO MEASURE C-ERBb-2 ONCOGENE AMPLIFICATION. | 1997 | GELMINI S; C. ORLANDO; SESTINI R; VONA G; PINZANI P; RUOCCO L; PAZZAGLI M | |
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors | 1998 | GELMINI S; CALDINI A; BECHERINI L; CAPACCIOLI S; PAZZAGLI M; C. ORLANDO | |
Evidence for elevated telomerase activity in small cell carcinoma of the bladder. | 2000 | SELLI C; GELMINI S; SCOTT CA; GIANNARINI G; C. ORLANDO | |
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas | 2000 | M. MANNELLI; GELMINI S.; ARNALDI G.; BECHERINI L.; BEMPORAD D.; CRESCIOLI C.; PAZZAGLI M.; MANTERO F.; SERIO M.; ORLANDO C. | |
luciferase gene as reporter: comparison with CAT gene and use in transfection and microinjection of mammalian cells | 2000 | GELMINI S; PINZANI P; M. PAZZAGLI | |
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. | 2000 | S. Gelmini; A. Crisci; B. Salvadori; M. Pazzagli; C. Selli; C. Orlando | |
Telomerase in urological malignancy | 2001 | C. ORLANDO; GELMINI S; SELLI C; PAZZAGLI M. | |
Telomerase in endocrine and endocrine-dependent tumors. | 2001 | C. ORLANDO; GELMINI S. | |
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. | 2001 | Peri A; Luciani P; Conforti B; Baglioni S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M | |
[Somatostatin receptors in non-endocrine tumours]. | 2001 | Casini Raggi C;Pinzani P;Gelmini S;Tricarico C;Orlando C;Calabrò A;Renzi D;Cianchi F;Valanzano R;Distante V;Cortesini C;Tonelli F;Cataliotti L;Cameron Smith M;Messerini L;Bianchi S;Pazzagli M;Serio M;Maggi M | |
Somatostatin receptors in non-endocrine tumours [Recettori per la somatostatina in tumori non endocrini.] | 2001 | Casini Raggi; C.; Pinzani; P.; Gelmini; S.; Tricarico; C.; Orlando; C.; Calabrò; A.; Renzi; D.; Cianchi; F.; Valanzano; R.; Distante; V.; Cortesini; C.; Tonelli; F.; Cataliotti; L.; Cameron Smith; M.; Messerini; L.; Bianchi; S.; Pazzagli; M.; Serio; M.; Maggi; M. | |
Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system. | 2001 | S. Gelmini; C. Tricarico; G. Vona; L. Livi; A. D. Melina; S. Serni; E. Cellai; S. Magrini; D. Villari; M. Carini; M. Serio; G. Forti; M. Pazzagli; C. Orlando | |
The significance of quantitative evaluation of telomerase activity and hTERT mRNA expression in colorectal cancers | 2002 | Poggesi M; Gelmini S; Casini Raggi C; Cianchi F; Valanzano R; Pazzagli M; Orlando C | |
Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate. | 2003 | Stefania Gelmini; Carmela Tricarico; Luisa Petrone; Gianni Forti; Andrea Amorosi; Giovanni L Dedola; Mario Serio; Mario Pazzagli; Claudio Orlando | |
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas. | 2004 | M. LOCATELLI; S. GELMINI; A. PERI; C. ORLANDO; M. FILOPANTI; E. BALLARÈ; A. LANIA; S. BONDIONI; U. VERGA; L. ZAVANONE; M. LOSA; P. BECK; A. SPADA | |
Resistin as a liver-derived cytokine that targets human hepatic stellate cells | 2004 | C. Bertolani; S. Aleffi; I. Petrai; B. Mazzinghi; S. Gelmini; P. Failli; C. Orlando; P. Romagnani; M. Parola; F. Marra; F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile